Report updated May 18, 2026
iComprendo
For healthcare professionals, medical students, and travelers requiring secure, offline, and medically accurate Spanish-English translation.
iComprendo is a market-leading medical app that is available. With a 5.0/5 rating from 1 reviews, it delivers strong user satisfaction. Users particularly value offline translation capability provides immediate utility for medical professionals working in remote or disconnected environments.
What is iComprendo?
iComprendo is a medically fluent, offline Spanish-English translation app for healthcare professionals on iOS and Android.
Users hire iComprendo to maintain HIPAA compliance during patient interactions, as the offline-only architecture removes the data-privacy risks associated with cloud-based translation services.
Current Momentum
v1.7 · 2mo ago
Maintenance- Ships general performance refinements.
- Last major release Sep 2025.
Active Nemesis
iTranslate Translator
By Mosaic S.r.l.
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
Recent User Mood
What makes this app unique?
What Does It Look Like?
Loading...
What Are The Key Features?
Processes Spanish-English translation locally without requiring Wi-Fi or cellular data
Includes thousands of drug names and specialized medical terms
Zero cloud storage or iCloud syncing of translation data
How much does it cost?
- Free trial for one month
- Premium tier at $12/year
Subscription model anchored at $12/year, positioning the app as a low-cost, specialized utility for healthcare professionals.
Who Built It?
What other apps does Anescribe make?
Spanislate: Medical Spanish
Medical
Elescan
Medical
Careslate: Medical Translator
Medical
Innaslide
Utilities
What do users think recently?
Low confidence · 1 reviews analyzed
How did the latest release land?
What is the recent mood?
Recent user voice shows a thrilled sentiment. Users appreciate offline translation capability provides immediate utility for medical professionals working in remote or disconnected environments.
Limited review volume (1 reviews). Sentiment analysis will deepen as more data lands.
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for iComprendo?
Where is it available?
Localized markets (1)
How's The Medical Market?
Market outlook for this category
Available very soon
The rivals identified
Nemeses(1)
iTranslate is the dominant market incumbent for general-purpose translation, competing directly for users seeking reliable offline language tools on mobile devices.
Differentiators
- Maintains a high release cadence with 16 updates in the last six months to ensure platform stability.
- Offers a broad, general-purpose translation feature set that appeals to a wider audience than medical-specific tools.
Contenders(4)
This app competes for users requiring specific, high-accuracy language pairs and voice-to-text functionality.
Duff Translate competes through its high-volume feature set and specialized translation modes for diverse user needs.
A direct competitor in the productivity space that offers multi-modal translation features for mobile users.
This app targets the same intersection of AI-driven voice translation and health-related utility as iComprendo.
Same space(3)
MISSIV targets professional users needing specialized text handling, overlapping with iComprendo's focus on professional-grade tools.
Unblur Text competes for the same utility-focused user who needs to process text from images in real-time.
This app integrates translation directly into the system keyboard, competing for the same 'quick-access' translation use case.
Compare iComprendo against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for iComprendo
Strengths to defend, gaps to attack
Core Strengths
- Privacy-first architecture ensures HIPAA compliance
- Specialized medical database creates barrier to entry
Critical Frictions
- Subscription tier above category median
- Zero Android user base
Growth Levers
- Medical school B2B distribution partnerships
- Integration with clinical EHR workflows
Market Threats
- DeepL release cadence threatens accuracy lead
- Google Translate free offline language packs
What are the next best moves?
Pivot marketing toward B2B medical school partnerships because the consumer-subscription price ceiling limits growth → increase enterprise-grade install velocity.
The $12/year price point faces a ceiling against free, ubiquitous competitors like Google Translate.
Trade-off: Pause the consumer-facing social media ad spend — B2B partnerships offer higher lifetime value.
Ship Android feature parity because the platform currently lacks a user base → capture the broader clinical workforce.
The app has 0 ratings on Android compared to a 5-star rating on iOS.
Trade-off: Deprioritize the camera-translation update — Android reach is a higher-impact growth lever.
A counter-intuitive read
The app's lack of a free tier is not a weakness but a signal of its B2B intent: medical professionals prioritize data security over price, making the $12/year subscription a trust-signaling mechanism.
Feature Gaps vs Competitors
- Real-time group conversation features (available in Microsoft Translator but absent here)
Key Takeaways
iComprendo secures clinical trust through offline privacy, but its growth is constrained by a paid-only model against free giants, so the PM should pivot toward B2B medical partnerships to escape the consumer price ceiling.
Where Is It Heading?
Stable
The medical translation market is consolidating around high-accuracy, privacy-focused tools, leaving general-purpose apps vulnerable to specialized entrants. iComprendo is well-positioned for clinical adoption but must expand its platform reach to avoid being sidelined by enterprise-grade alternatives.
The offline-first architecture provides a clear value proposition for clinical settings, insulating the app from general-purpose translation market volatility.
The lack of Android traction (zero ratings) limits the app's reach in the broader clinical workforce, which compounds the risk of being outpaced by high-velocity competitors.